MedTrace Logo

Uncertainty Management Intervention

NCT00938795 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 288

Last updated 2014-02-07

No results posted yet for this study

Summary

The goal of this study is to improve symptoms and quality of life for end-stage liver disease patients awaiting a liver transplant and their caregivers by providing them with the resources and tools to self-manage their complex concerns.

Conditions

Interventions

OTHER

Uncertainty Management Intervention

Six 30-minute telephone calls with a nurse to discuss emotional and physical aspects of liver disease and awaiting liver transplant

OTHER

Comparison Conditions for Liver Transplant

Six 30-minute telephone calls that provide structured education about liver disease.

Sponsors & Collaborators

  • National Institute of Nursing Research (NINR)

    collaborator NIH

  • Duke University

    lead OTHER

Principal Investigators

  • James Tulsky, MD · Duke University School of Nursing

  • Donald Bailey, PhD · Duke University School of Nursing

  • Annette Devito Dabbs, PhD, RN · The University of Pittsburgh

  • Paul H. Hayashi, MD, MPH · University of North Carolina, Chapel Hill

  • Laurel Williams-Salonen, RN,MSN,CCTC · The University of Nebraska Medical Center

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2013-09-30
Completion
2013-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00938795 on ClinicalTrials.gov